English | Español
Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Patient Daily Report | May 5, 2023

Eli Lilly on new Alzheimer's drug: 'We are extremely pleased that donanemab yielded positive clinical results'
Patient Daily | May 4, 2023

Device Talks Boston 2023
Patient Daily | May 4, 2023

Patagonia Health Certified as an NC Minority-Owned Business
Patient Daily | May 4, 2023

RELIAS HONORED AS STEVIE AWARD WINNER FOR CUSTOMER SERVICE DEPARTMENT OF THE YEAR IN 2023 AMERICAN BUSINESS AWARDS

Patient Daily | May 4, 2023

RELIAS ANNOUNCES UPDATES TO LEARNER MOBILE APP
Patient Daily | May 4, 2023

NURSE.COM CELEBRATES NURSES DURING NATIONAL NURSES WEEK

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’